The FDA approved a supplemental new drug application for ruxolitinib cream 1.5% for the short-term and noncontinuous ...

Artificial intelligence has taken many forms over the years and is still evolving. Will machines soon surpass human knowledge ...

Local districts departed from some national trends. But girls’ scores still slid more than boys’, with a few exceptions.

Kamala Harris’s loss in last November’s presidential election produced few prominent claims of fraud, and nothing like the ...

For more LA stories like this, sign up for our new weekly newsletter, The Southland. You'll get features, profiles, histories ...

Justice B M Shyam Prasad, while disposing of a petition filed by Dror Shlomo Goldstein, permitted the Centre to issue exit ...

The glorious visit of US President Donald Trump to the British Isles last week came with promises of thousands of precious ...

Community Foundations of the Hudson Valley is partnering with WAMC "On the Road" to host a panel discussion called " Housing ...

Pumpkin patches in Texas have varying dates of operation, with some opening in early September. It's hard to say for sure where the largest pumpkin patch in Texas really is. But at 152 acres, Sweet ...

A ribbon cutting ceremony for the lab, which the district recently acquired thanks to an anonymous donor, will be held at Beecher High School in Mt. Morris on Oct. 1.

Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opzelura ® (ruxolitinib) cream 1.5%, a topical Janus kinase (JAK) inhibitor, for the short-term and ...

From tech titans and international hotel brands to down-home Texas fare and online car shopping, the matchups run from familiar to delightfully unexpected -- plus plenty of banter.